Search research articles
Contact Us
Filters
Showing results (111-120 of 307) with videos related to
Page
of 31
Sort By:
Lancet (London, England)
|
February 7, 1987
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen
M Manns, G Gerken, A Kyriatsoulis, et al.
European Journal of Gastroenterology & Hepatology
|
July 28, 2001
Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats
J M Zeeh, N E Riley, P Hoffmann, et al.
Experimental and Clinical Immunogenetics
|
January 1, 1996
Antigen-processing polymorphisms in chronic hepatitis C infection
T Höhler, G Gerken, P M Schneider, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
June 15, 1996
[Significance of antineutrophil cytoplasmic antibodies (ANCA) in diagnosis and immunopathogenesis of chronic inflammatory liver diseases]
W J Mayet, T Orth, A Schwarting, et al.
Journal of Virological Methods
|
October 21, 1998
Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay
G Gerken, J Gomes, P Lampertico, et al.
Journal of Hepatology
|
January 1, 1997
Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1
T Orth, G Gerken, R Kellner, et al.
Gastroenterology
|
June 1, 1987
Pre-S encoded surface proteins in relation to the major viral surface antigen in acute hepatitis B virus infection
G Gerken, M Manns, W H Gerlich, et al.
Alimentary Pharmacology & Therapeutics
|
January 7, 2011
A 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors
S Haag, J M Andrews, J Gapasin, et al.
Zeitschrift Fur Gastroenterologie
|
July 1, 1997
Coombs-negative severe hemolysis associated with hepatitis A
M Ibe, B Rüde, G Gerken, et al.
Journal of Hepatology
|
February 12, 1998
Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapy
J F Schlaak, M Trippler, I Ernst, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 307) with videos related to
Sort By:
Page
of 31
Lancet (London, England)
|
February 7, 1987
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen
M Manns, G Gerken, A Kyriatsoulis, et al.
European Journal of Gastroenterology & Hepatology
|
July 28, 2001
Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats
J M Zeeh, N E Riley, P Hoffmann, et al.
Experimental and Clinical Immunogenetics
|
January 1, 1996
Antigen-processing polymorphisms in chronic hepatitis C infection
T Höhler, G Gerken, P M Schneider, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
June 15, 1996
[Significance of antineutrophil cytoplasmic antibodies (ANCA) in diagnosis and immunopathogenesis of chronic inflammatory liver diseases]
W J Mayet, T Orth, A Schwarting, et al.
Journal of Virological Methods
|
October 21, 1998
Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay
G Gerken, J Gomes, P Lampertico, et al.
Journal of Hepatology
|
January 1, 1997
Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1
T Orth, G Gerken, R Kellner, et al.
Gastroenterology
|
June 1, 1987
Pre-S encoded surface proteins in relation to the major viral surface antigen in acute hepatitis B virus infection
G Gerken, M Manns, W H Gerlich, et al.
Alimentary Pharmacology & Therapeutics
|
January 7, 2011
A 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors
S Haag, J M Andrews, J Gapasin, et al.
Zeitschrift Fur Gastroenterologie
|
July 1, 1997
Coombs-negative severe hemolysis associated with hepatitis A
M Ibe, B Rüde, G Gerken, et al.
Journal of Hepatology
|
February 12, 1998
Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapy
J F Schlaak, M Trippler, I Ernst, et al.
Page
of 31